Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study118

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study25

Views

Views
December 20253
January 20262
February 20260
March 20263
April 20264
May 202611
June 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Argentina6
United States5
Mexico2
United Kingdom2
Bolivia1
Switzerland1
Chile1
Colombia1
Germany1
Finland1
 

Top cities views

Views
Ashburn2
Casablanca1
Chesapeake1
Ciudadela1
Crowthorne1
Frankfurt am Main1
Fribourg1
Groningen1
Helsinki1
Ituzaingó1